Biography
Dr. Andrew Kung is a physician-scientist whose clinical practice is focused on cancer genomics, precision cancer medicine and stem cell transplantation. The overarching goal of his patient-driven research program is to identify new causes of and treatments for childhood and young adult cancers. The translational oncology research in his laboratory is powered by the integration of diverse experimental approaches including genomics, data science, experimental therapeutics, and human clinical studies. His laboratory has advanced several novel therapeutic strategies to the clinic for hematologic malignancies, solid tumors, and brain tumors.
Track Chair: Hakan Sakul, Pfizer